SCHEMBL34638

SCHEMBL34638

O=C(O)NN1CCCCC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.52
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 1/20 0.42
TP53 P04637 1/20 0.42
GLA P06280 1/20 0.42
CYP3A4 P08684 1/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
ALOX12 P18054 1/20 0.42
NFKB1 P19838 1/20 0.42
LIPE Q05469 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
CYP1A2 P05177 1/20 0.38
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CNR1 P21554 4/20 0.37
CNR2 P34972 2/20 0.36
EPHX2 P34913 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9727085 1.00 HTT (0.52) HTTALDH1A1KDM4ETP53GLA
Hydrochloric Acid SCHEMBL8939931 0.97 HTT (0.50) HTTALDH1A1KDM4ETP53GLA
SCHEMBL477228 0.97
Benzene SCHEMBL8030551 0.95 HTT (0.59) HTTALDH1A1KDM4ETP53GLA
Hydrochloric Acid SCHEMBL11600093 0.94 HTT (0.47) HTTALDH1A1KDM4ETP53GLA
Benzene SCHEMBL3841909 0.92 HTT (0.55) HTTALDH1A1KDM4ETP53GLA
SCHEMBL1801925 0.92
SCHEMBL10879021 0.89 HTT (0.44) HTTALDH1A1KDM4ETP53GLA
SCHEMBL18124344 0.89 HTT (0.44) HTTALDH1A1KDM4ETP53GLA
Piperidine SCHEMBL25200840 0.87 HTT (0.43) HTTALDH1A1KDM4ETP53GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 995 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9353109-B2 Flindersia alkaloids, derivatives and analogs: compositions and methods for producing the same UNIVERSITY OF HOUSTON SYSTEM (US) 2016-05-31 US claimed
US-9179994-B2 Implantable film/mesh composite COVIDIEN LP (US) 2015-11-10 US claimed
US-20150299196-A1 Flindersia Alkaloids, Derivatives and Analogs: Compositions and Methods for Producing the Same UNIVERSITY OF HOUSTON SYSTEM (US) 2015-10-22 US claimed
US-9067946-B2 Flindersia alkaloids, derivatives and analogs: compositions and methods for producing the same UNIVERSITY OF HOUSTON SYSTEM (US) 2015-06-30 US claimed
US-9005308-B2 Implantable film/mesh composite for passage of tissue therebetween COVIDIEN LP (US) 2015-04-14 US claimed
US-8932621-B2 Implantable film/mesh composite COVIDIEN LP (US) 2015-01-13 US claimed
US-20140142520-A1 IMPLANTABLE DEVICES INCLUDING A MESH AND A PIVOTABLE FILM COVIDIEN LP (US) 2014-05-22 US claimed
EP-2586400-B1 Implantable film/Mesh composite COVIDIEN LP (US) 2014-03-19 EP claimed
EP-2586401-B1 Implantable film/mesh composite COVIDIEN LP (US) 2014-03-19 EP claimed
US-20130190511-A1 Flindersia Alkaloids, Derivatives and Analogs: Compositions and Methods for Producing the Same HOUSTON SYSTEM, UNIVERSITY OF 2013-07-25 US claimed
US-6282837-B1 Methods of controlling the growth of undesired vegetation with herbicide tolerant plants or plant seeds having altered protoporphyrinogen oxidase activity NOVARTIS FINANCE CORPORATION 2001-09-04 US claimed
US-20010016956-A1 Herbicide-tolerant protox genes produced by DNA shuffling WARD ERIC R (US) 2001-08-23 US claimed
WO-2001012825-A1 HERBICIDE-TOLERANT PROTOPORPHYRINOGEN OXIDASE SYNGENTA PARTICIPATIONS AG (CH) 2001-02-22 WO claimed
US-5939602-A GENETICALLY ENGINEERED PLANTS EXPRESSING HERBICIDE TOLERANT PROTOX ENZYMES NOVARTIS FINANCE CORPORATION (US) 1999-08-17 US claimed
EP-0883682-A1 DNA MOLECULES ENCODING PLANT PROTOPORPHYRINOGEN OXIDASE AND INHIBITOR-RESISTANT MUTANTS THEREOF Novartis AG (CH) 1998-12-16 EP claimed
WO-1997032011-A1 DNA MOLECULES ENCODING PLANT PROTOPORPHYRINOGEN OXIDASE AND INHIBITOR-RESISTANT MUTANTS THEREOF NOVARTIS AG (CH) 1997-09-04 WO claimed
EP-0769059-A1 MANIPULATION OF PROTOPORPHYRINOGEN OXIDASE ENZYME ACTIVITY IN EUKARYOTIC ORGANISMS Novartis AG (CH) 1997-04-23 EP claimed
US-5480989-A Carbamates of rapamycin AMERICAN HOME PRODUCTS CORPORATION (US) 1996-01-02 US claimed
WO-1995034659-A1 MANIPULATION OF PROTOPORPHYRINOGEN OXIDASE ENZYME ACTIVITY IN EUKARYOTIC ORGANISMS CIBA-GEIGY AG (CH) 1995-12-21 WO claimed
US-5411967-A Antiinflammatory, immunosuppressant, antitumor AMERICAN HOME PRODUCTS CORPORATION (US) 1995-05-02 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130190511-A1 Flindersia Alkaloids, Derivatives and Analogs: Compositions and Methods for Producing the Same NAAA, MAOA, AANAT HTT 480/4885ALDH1A1 2072/4885KDM4E 1971/4885
US-20150299196-A1 Flindersia Alkaloids, Derivatives and Analogs: Compositions and Methods for Producing the Same MAOA, NAAA, FLNA HTT 472/4885ALDH1A1 2383/4885KDM4E 1977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.